Becky Schultz speaks with founder and CEO of Transient Plasma Systems, Dan Singleton, about the company’s plasma-based aftertreatment and...

Read more
By: Kairos Ventures On: January 19, 2023 In: Linnaeus, Portfolio News

Linnaeus Therapeutics announced that the FDA has granted orphan drug designation for LNS8801 for the treatment of patients with...

Read more
By: Kairos Ventures On: January 18, 2023 In: MemVerge, Portfolio News

MemVerge announced that Jeffrey Wang has been named Vice President of Engineering. With decades of software-defined infrastructure experience across...

Read more
By: Kairos Ventures On: January 11, 2023 In: Applaud Medical, Portfolio News

Applaud Medical announced the appointment of industry veteran Paul Molloy as CEO. The company has also added Molloy to...

Read more
By: Kairos Ventures On: January 10, 2023 In: MemVerge, Portfolio News

MemVerge Memory Machine™ is the first software-defined Compute Express Linkä (CXLä) memory management solution to offer support for the...

Read more

A new trial sponsored by Axial Therapeutics will test whether a medication that targets gut bacteria can also improve...

Read more
By: Kairos Ventures On: December 5, 2022 In: Portfolio News, Vivodyne

Vivodyne announced today that it has expanded its executive team with Dr. Susan Billings joining as its Chief Commercial...

Read more
By: Kairos Ventures On: December 2, 2022 In: MixComm, Portfolio News

Sivers Semiconductors AB announced that its business unit, Sivers Wireless, has signed a strategic development agreement worth $16.4 million...

Read more
By: Kairos Ventures On: December 1, 2022 In: 3D Bio, Portfolio News

About 1,500 people in the US are born each year with absent or underdeveloped external ears. Traditional reconstruction techniques...

Read more
By: Kairos Ventures On: November 30, 2022 In: Portfolio News, Sienza Energy

As the European market is at the forefront of adopting electric cars, it was logical for Sienza Energy to...

Read more